182 related articles for article (PubMed ID: 20738834)
41. Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report.
Eschertzhuber S; Velik-Salchner C; Hoermann C; Hoefer D; Lass-Florl C
Transpl Infect Dis; 2008 Jun; 10(3):190-2. PubMed ID: 17605738
[TBL] [Abstract][Full Text] [Related]
42. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
Shang W; Feng G; Sun R; Wang X; Liu W; Zhang S; Li J; Pang X; Wang Y; Zhang W
J Clin Pharm Ther; 2012 Dec; 37(6):652-6. PubMed ID: 22725946
[TBL] [Abstract][Full Text] [Related]
43. Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia.
Petit A; Levine E; Epaud R; Le Pointe HD; Angoulvant A
Lancet Infect Dis; 2011 May; 11(5):416. PubMed ID: 21530896
[No Abstract] [Full Text] [Related]
44. Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
Alanio A; Brethon B; Feuilhade de Chauvin M; de Kerviler E; Leblanc T; Lacroix C; Baruchel A; Menotti J
Clin Infect Dis; 2008 May; 46(10):e116-8. PubMed ID: 18419477
[TBL] [Abstract][Full Text] [Related]
45. Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
La Nasa G; Littera R; Maccioni A; Ledda A; Vacca A; Contu L
Hematol J; 2004; 5(2):178-80. PubMed ID: 15048069
[TBL] [Abstract][Full Text] [Related]
46. Combination antifungal therapy for invasive aspergillosis.
Marr KA; Boeckh M; Carter RA; Kim HW; Corey L
Clin Infect Dis; 2004 Sep; 39(6):797-802. PubMed ID: 15472810
[TBL] [Abstract][Full Text] [Related]
47. Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.
Can MF; Yagci G; Gorenek L; Tozkoparan E; Ozerhan I; Cetiner S
Surg Infect (Larchmt); 2008 Feb; 9(1):99-104. PubMed ID: 18363474
[TBL] [Abstract][Full Text] [Related]
48. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
49. Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.
Peláez T; Muñoz P; Guinea J; Valerio M; Giannella M; Klaassen CH; Bouza E
Clin Infect Dis; 2012 Feb; 54(3):e24-31. PubMed ID: 22247307
[TBL] [Abstract][Full Text] [Related]
50. Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Shlobin OA; Dropulic LK; Orens JB; Mcdyer JF; Conte JV; Yang SY; Girgis R
J Heart Lung Transplant; 2005 Nov; 24(11):1991-4. PubMed ID: 16297812
[TBL] [Abstract][Full Text] [Related]
51. Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole.
Kuipers S; Brüggemann RJ; de Sévaux RG; Heesakkers JP; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2011 Jul; 55(7):3564-6. PubMed ID: 21502625
[TBL] [Abstract][Full Text] [Related]
52. Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
Calvo E; Pastor FJ; Salas V; Mayayo E; Guarro J
Mycopathologia; 2012 Apr; 173(4):251-7. PubMed ID: 22139415
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
54. Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole.
Wéclawiak H; Garrouste C; Kamar N; Linas MD; Tall P; Dambrin C; Durand D; Rostaing L
Transplant Proc; 2007 Oct; 39(8):2627-8. PubMed ID: 17954195
[TBL] [Abstract][Full Text] [Related]
55. Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
Forghieri F; Rossi G; Potenza L; Morselli M; Barozzi P; Vallerini D; Messino M; Rumpianesi F; Pecorari M; Torelli G; Luppi M
Am J Hematol; 2010 Mar; 85(3):188-9. PubMed ID: 19507207
[No Abstract] [Full Text] [Related]
56. CNS-aspergillosis: are there new treatment options?
Schwartz S; Thiel E
Mycoses; 2003; 46 Suppl 2():8-14. PubMed ID: 15055138
[TBL] [Abstract][Full Text] [Related]
57. Disseminated invasive aspergillosis successfully treated with micafungin in a renal transplant recipient.
Wadi J; Al-kawasmeh SI; Kamel MT; AlJayyousi BB
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):914-8. PubMed ID: 20814131
[TBL] [Abstract][Full Text] [Related]
58. Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Stratakos G; Zakynthinos S
Respiration; 2007; 74(6):609-10. PubMed ID: 18037812
[No Abstract] [Full Text] [Related]
59. Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
Mathis AS; Shah NK; Friedman GS
Transplant Proc; 2004 Nov; 36(9):2708-9. PubMed ID: 15621130
[TBL] [Abstract][Full Text] [Related]
60. Aspergillus fumigatus joint infection: a review.
Golmia R; Bello I; Marra A; Hamerschlak N; Osawa A; Scheinberg M
Semin Arthritis Rheum; 2011 Jun; 40(6):580-4. PubMed ID: 20843541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
